Multimodality treatment for hormone-naïve metastatic prostate cancer
Does radical prostatectomy have an impact on long-term outcomes of patients with metastatic prostate cancer?
Date
09 Oct 2016Session
Multimodality treatment for hormone-naïve metastatic prostate cancerPresenters
Axel HeidenreichAuthors
A. HeidenreichAuthor affiliations
- Universitätsklinikum Köln, 50937 - Cologne/DE
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
Docetaxel for prostate cancer: Best timing and right patient
Presenter: Nick James
Session: Multimodality treatment for hormone-naïve metastatic prostate cancer
Resources:
Slides
Webcast
Radiation to the primary tumour in metastatic disease: When and whom
Presenter: Alberto Bossi
Session: Multimodality treatment for hormone-naïve metastatic prostate cancer
Resources:
Webcast